
2006, Top Docs for Kids, (Pediatric Hematology/Oncology), Philadelphia Magazine
2005, Top Docs for Kids, (Pediatric Hematology/Oncology), Philadelphia Magazine
2004, Top Docs for Kids, (Pediatric Hematology/Oncology), Philadelphia Magazine
2001, Fellow, American Association for the Advancement of Science
1997, John Morgan Society at the University of Pennsylvania
1995, Honorary Masters of Arts Degree, University of Pennsylvania
1994, The Audrey E. Evans Endowed Chair in Pediatric Oncology, The Children's Hospital of Philadelphia
1990, Alpha Omega Alpha
1985-1990, Research Career Development Award, National Institutes of Health
1985-1990, John A. and George L. Hartford Foundation Research Fellowship
1984-1985, Basil O'Conner Starter Research Grant, March of Dimes
1982-1985, Junior Faculty Clinical Fellowship, American Cancer Society
1975, St. Louis Pediatric Society Award, Washington Univ. School of Medicine
1975, Richard S. Brookings Research Award for Meritorious Research, Washington University School of Medicine
1971, Magna Cum Laude, St. Louis University
1971, Phi Beta Kappa, St. Louis University
1971, Alpha Sigma Nu, St. Louis University
1990-present, Cancer and Metastasis Reviews
1989-present, Genes, Chromosomes and Cancer
1987-present, Medical and Pediatric Oncology
1982-present, Cancer Genetics and Cytogenetics
Pediatric Oncology Tumor Board: Neuroblastoma, August 2005
Cancer Pharmacology Course (PHRM 560), U. Penn, Tyrosine kinases as targets for future therapy, February 2006
1980-present, American Society of Hematology
1980-present, American Society of Clinical Oncology
1981-present, American Association for Cancer Research
1983-present, American Society for Microbiology
1983-present, American Association for the Advancement of Science
1983-present, American Society of Pediatric Hematology-Oncology
1985-present, Society for Pediatric Research
1989-present, American Society of Human Genetics
1990-present, American Society for Clinical Investigation
2001-present, Member, Osler Interurban Clinical Club
1986-present, Scientific Advisory Board, National Cancer Center, New York, NY
1989-1999, Scientific Advisory Board, Quebec Neuroblastoma Screening, Program Project, Montreal, Canada
1991-2000, Scientific Advisory Board, William G. Forbeck Research Foundation, Hilton Head Island, SC
2000-present , Scientific Advisory Board, The Fred Hutchinson Cancer Center, Seattle WA
2006-present , Scientific Advisory Board, Harriet W. Samuelsson Foundation
2000-present , Neuroblastoma, Strategy Committee, COG
1997-present , Program Leader of Pediatric Oncology, Univ. of Pennsylvania Cancer Center
Minturn JE, Evans AE, Villablanca JG, Yanik GA, Park JR, Shusterman S, et al. Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study. Cancer Chemother Pharmacol. Epub 2011 Feb 22. Cited in PubMed: PMID 21340605. Read the abstract
Brodeur GM. Getting into the AKT. J Natl Cancer Inst. 2010 Jun 2;102(11):747-9. 2010 Jun 2;102(11):747-9. Epub 2010 May 12. Cited in PubMed: PMID 20463308. Read the article
Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, et al. Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res. 2009 May 15;15(10):3244-50. Epub 2009 May 5. Cited in PubMed: PMID 19417027. Read the article
Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer. 2009 May 5;100(9):1471-82. Cited in PubMed: PMID 19401703. Read the article
Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, et al. INRG Task Force. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009 Jan 10;27(2):289-97. Epub 2008 Dec 1. Cited in PubMed: PMID 19047291. Read the article